United States · FDA National Drug Code directory
MENQUADFI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-6180_f80a021d-0cae-4b0e-b3e0-95c32fa4f0df
- Product NDC
- 50090-6180
- Form
- INJECTION, SOLUTION
- Composition / generic term
- NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN
- Labeler
- A-S Medication Solutions
- Marketing category
- BLA
- Marketing start / end (source format)
- 20200423
- Source listing expiry
- 20261231
Source-listed ingredients
- NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN — 10 ug/.5mL
- NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN — 10 ug/.5mL
- NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN — 10 ug/.5mL
- NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN — 10 ug/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 VIAL, SINGLE-DOSE in 1 CARTON (50090-6180-0) / .5 mL in 1 VIAL, SINGLE-DOSE (50090-6180-1) · 50090-6180-0
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →